VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Indivior Pharmaceuticals Inc (INDV) Total Return Calculator with Dividends Reinvested

Indivior Pharmaceuticals Inc

Popular:

The total return for Indivior Pharmaceuticals Inc (INDV) stock is +247.09% over the past 12 months. So far it's up 13.66% this year. The 5-year total return is +284.93%, meaning $10,000 invested in INDV stock 5 years ago would be worth $38,493 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in INDV 1 year ago, it would be worth $35,375 today — you'd have gained $25,375.

With Dividends Reinvested$35,375+253.75%

Price Only (No DRIP)$35,375+253.75%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in INDV

1Y$34,709+$24,709 (+247.1%)247.1% CAGR

3Y$20,204+$10,204 (+102.0%)26.4% CAGR

5Y$38,493+$28,493 (+284.9%)30.9% CAGR

10Y$39,129+$29,129 (+291.3%)14.6% CAGR

15Y$38,727+$28,727 (+287.3%)9.4% CAGR

20Y$38,728+$28,728 (+287.3%)7.0% CAGR

30Y$38,727+$28,727 (+287.3%)4.6% CAGR

Indivior Pharmaceuticals Inc did not pay dividends during this period. Total return = price return.

Loading INDV total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+13.66%	—	+13.66%	—	$11,366
1Y	+247.09%	247.09%	+247.09%	—	$34,709
3Y	+102.04%	26.42%	+102.04%	—	$20,204
5Y	+284.93%	30.94%	+284.93%	—	$38,493
10Y	+291.29%	14.62%	+286.76%	+4.52 pp	$39,129
15Y	+287.27%	9.45%	+281.31%	+5.96 pp	$38,727
20Y	+287.28%	7.00%	+281.32%	+5.96 pp	$38,728
30Y	+287.27%	4.62%	+281.31%	+5.96 pp	$38,727

Risk & Highlights

Best Year+187.04%2025

Worst Year-75.45%2018

Max Drawdown-21.37%2025-12-08 → 2026-03-30 · Recovered 2026-04-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-8.42%	-8.42%	—	+0.41%	-8.8pp
2025	+187.04%	+187.04%	—	+16.64%	+170.4pp
2024	-19.65%	-19.65%	—	+24.00%	-43.6pp
2023	-29.79%	-29.79%	—	+24.81%	-54.6pp
2022	+31.42%	+31.42%	—	-19.95%	+51.4pp

INDV outperformed the S&P 500 by 215.77pp over the past year (+247.09% vs +31.32%).

Loading summary...

INDV Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
INDVIndivior Pharmaceuticals Inc	$5.1B	+33.5%	+13.7%	+247.1%	—	+102.0%	+284.9%	+291.3%
RBBNRibbon Communications Inc.	$471M	+19.6%	-7.6%	-13.8%	—	+1.5%	-59.5%	-67.7%
AVPTAvePoint, Inc.	$2.2B	+2.4%	-22.3%	-39.5%	—	+131.8%	+1.1%	+5.0%
BHVNBiohaven Ltd.	$1.1B	+9.7%	-7.4%	-47.6%	—	-29.3%	+37.5%	+37.5%
ALKSAlkermes plc	$5.9B	+3.6%	+25.0%	+16.3%	—	+14.3%	+60.5%	-7.7%
BHCBausch Health Companies Inc.	$2.1B	+4.4%	-21.6%	+19.2%	—	-5.7%	-79.6%	-81.1%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
COLLCollegium Pharmaceutical, Inc.	$1.2B	+12.0%	-19.8%	+35.1%	—	+55.9%	+66.4%	+141.8%
MTLSMaterialise N.V.	$332M	+13.1%	+3.1%	+6.2%	—	-36.6%	-78.9%	-16.7%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
PCRXPacira BioSciences, Inc.	$932M	+6.4%	-3.1%	-5.8%	—	-43.9%	-62.5%	-50.0%

Compare:INDV vs RBBN INDV vs AVPT INDV vs BHVN INDV vs RBBN vs AVPT

About INDV Dividend Returns

Indivior Pharmaceuticals Inc (INDV) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of INDV over the past year?

Indivior Pharmaceuticals Inc (INDV) delivered a return of 247.09% over the past year. Since INDV does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in INDV be worth today?

A $10,000 investment in Indivior Pharmaceuticals Inc one year ago would be worth $34,709 today, representing a gain of $24,709.

Q3Does INDV pay dividends?

Indivior Pharmaceuticals Inc (INDV) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For INDV, the total return equals the price-only return.

Q4Did INDV beat the S&P 500?

Yes, Indivior Pharmaceuticals Inc (INDV) outperformed the S&P 500 by 215.77 percentage points over the past year. INDV delivered a total return of 247.09%, compared to the S&P 500's 31.32%. This 215.77pp alpha means investors in INDV earned more than a passive S&P 500 index fund.

Q5What is INDV's worst drawdown?

Indivior Pharmaceuticals Inc (INDV) experienced a maximum drawdown of -21.37% over the past year, declining from its peak on 2025-12-08 to its trough on 2026-03-30. The stock recovered to its prior peak by 2026-04-30. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is INDV's long-term total return over 10, 20, or 30 years?

Here are Indivior Pharmaceuticals Inc (INDV)'s long-term returns with dividends reinvested. Over 10 years, the total return is 291.3% (14.6% CAGR) — $10,000 would have grown to $39,129. Over 20 years: 287.3% total return (7.0% CAGR) — $10,000 → $38,728. Over 30 years: 287.3% total return (4.6% CAGR) — $10,000 → $38,727. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was INDV's best and worst year?

Indivior Pharmaceuticals Inc's best calendar year was 2025 with a total return of 187.0%. Its worst year was 2018 with a total return of -75.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 262.5 percentage points.